Luming Chen

Luming Chen

Auto-generated profile, based on publicly available information

Luming Chen

Medical Scientist Training Program, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-8505, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2010 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
NLNyall R. London
Nyall R. London
WZWeiquan Zhu
Weiquan Zhu
FBFernando Bozza
Fernando Bozza
MSMatthew C. P. Smith
Matthew C. P. Smith
DGDaniel M. Greif
Daniel M. Greif
DLDean Y. Li
Dean Y. Li
Blunting increased vascular permeability caused by an infection-induced cytokine storm with a Slit ligand increased survival in rodent models of sepsis and viral infection.

1 October 2019 in Journal of Molecular Biology
Verified
Journal Article
Closed access
NNNicole J. De Nisco
Nicole J. De Nisco
MNMichael Neugent
Michael Neugent
JMJason Mull
Jason Mull
LCLuming Chen
Luming Chen
AKAmy Kuprasertkul
Amy Kuprasertkul
KOKim Orth
Kim Orth

1 March 2017 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
JWJingnan Wang
Jingnan Wang
JTJiayun Tan
Jiayun Tan
JLJiahao Luo
Jiahao Luo
PHPeilin Huang
Peilin Huang
WZWuyi Zhou
Wuyi Zhou
DDDavid Y.B. Deng
David Y.B. Deng
Diabetic retinopathy is the most common complication in diabetic patients relates to high expression of VEGF and microaneurysms. Scutellarin (Scu) turned out to be effective against diabetes related vascular endothelial cell dysfunction. However, its clinical applications have been limited by its low bioavailability. In this study, we formulated and characterized a novel intestinal target nanoparticle carrier based on amphiphilic chitosan derivatives (Chit-DC-VB12) loaded with scutellarin to enhance its bioavailability and then evaluated its therapeutic effect in experimental diabetic retinopathy model. Chit-DC-VB12 nanoparticles showed low toxicity toward the human colon adenocarcinoma (Caco-2) cells and zebra fish within concentration of 250 μg/ml, owing to good biocompatibility of chitosan. The scutellarin-loaded Chit-DC-VB12 nanoparticles (Chit-DC-VB12-Scu) were then prepared by self-assembly in aqueous solution. Scanning electron microscopy and dynamic light scattering analysis indicated that the Chit-DC-VB12-Scu nanoparticles were spherical particles in the sizes ranging from 150 to 250 nm. The Chit-DC-VB12-Scu nanoparticles exhibited high permeation in Caco-2 cell, indicated it could be beneficial to be absorbed in humans. We also found that Chit-DC-VB12 nanoparticles had a high cellular uptake. Bioavailability studies were performed in Sprague–Dawley rats, which present the area under the curve of scutellarin of Chit-DC-VB12-Scu was two to threefolds greater than that of free scutellarin alone. Further to assess the therapeutic efficacy of diabetic retinopathy, we showed Chit-DC-VB12-Scu down-regulated central retinal artery resistivity index and the expression of angiogenesis proteins (VEGF, VEGFR2, and vWF) of retinas in type II diabetic rats. Chit-DC-VB12 nanoparticles loaded with scutellarin have better bioavailability and cellular uptake efficiency than Scu, while Chit-DC-VB12-Scu nanoparticles alleviated the structural disorder of intraretinal neovessels in the retina induced by diabetes, and it also inhibited the retinal neovascularization via down-regulated the expression of angiogenesis proteins. In conclusion, the Chit-DC-VB12 nanoparticles enhanced scutellarin oral delivery efficacy and exhibited potential as small intestinal target promising nano-carriers for treatment of type II diabetes induced-retinopathy.

1 June 2012 in Biomaterials
Verified
Journal Article
Closed access
YZYanfang Zhou
Yanfang Zhou
BYBin Yang
Bin Yang
XRXianyue Ren
Xianyue Ren
ZLZhenzhen Liu
Zhenzhen Liu
ZDZheng Deng
Zheng Deng
LYLiqun Yang
Liqun Yang

1 February 2013 in Biomaterials
Verified
Journal Article
Closed access
HWHong-Fu Wu
Hong-Fu Wu
JCJing-Sheng Cen
Jing-Sheng Cen
QZQian Zhong
Qian Zhong
LCLuming Chen
Luming Chen
JWJue Wang
Jue Wang
YWYong Wan
Yong Wan

1 January 2014 in Biomaterials
Verified
Journal Article
Closed access
HZHong-Wu Zhang
Hong-Wu Zhang
LWLi-Qin Wang
Li-Qin Wang
QXQing-Feng Xiang
Qing-Feng Xiang
QZQian Zhong
Qian Zhong
LCLu-Ming Chen
Lu-Ming Chen
DDDavid Y.B. Deng
David Y.B. Deng